How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore

Journal of Viral Hepatitis

Volumn 16, Issue 1, 2009, Pages 53-63

  Ong, S C ^b   Lim, S G ^c,d,e   Li, S C ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e AGENCY FOR SCIENCE   (Singapore)

Author keywords

Chronic hepatitis B; Cost of illness analysis; Direct cost; Financial burden; Hepatitis B virus infection; Indirect cost

Indexed keywords

ADULT; ARTICLE; CAREGIVER; CONTROLLED STUDY; COST OF ILLNESS; DECOMPENSATED LIVER CIRRHOSIS; DISEASE SEVERITY; ECONOMIC ASPECT; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH SURVEY; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; PATIENT SELECTION; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS; SINGAPORE;

ADULT; AGED; AGED, 80 AND OVER; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HEPATITIS B; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SINGAPORE;

EID: 58149088997     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2008.01042.x     Document Type: Article

References (29)

1. Lok AS. Chronic hepatitis B. N Engl J Med 2002 346 (22 1682 1683.
2. Beasley RP. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 1988 61 : 1942 1956.
3. Chen CJ, Yang HI, Su J et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006 1 : 65 73.
4. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981 2 (8256 1129 1133.
5. Johnson PJ. Benign and malignant tumors of the liver. In : Bacon BR, Di Bisceglie AM, eds. Liver Disease Diagnosis and Management. Philadelphia, PH : Churchill Livingstone, 2000 : 311 313.
6. Goh KT. Prevention and control of hepatitis B virus infection in Singapore. Ann Acad Med Singapore 1997 26 (5 671 681.
7. Guan R. Hepatitis B virus infection in Singapore. Gut 1996 38 (Suppl. 2 S13 S17.
8. Seow A, Koh WP, Chia KS, Shi LM, Lee HP, Shanmugaratnam K. Trends in Cancer Incidence in Singapore 1968-2002. Singapore Cancer Registry, Report No. 6, 2004 : 100 101.
9. Pokorski RJ, Ohlmer U. Long-term morbidity and mortality in Chinese insurance applicants infected with the hepatitis B virus. J Insur Med 2001 33 (2 143 164.
10. Lemon SM, Layden TJ, Seeff L et al. The 20th United States-Japan Joint Hepatitis Panel Meeting. Hepatology 2000 31 (3 800 806.
11. Oon CJ. Liver cancer in Singapore - an overview. Singapore Med J 1987 28 : 410 414.
12. Yang BM, Paik SW, Hahn OS, Yi DH, Choi MS, Payne S. Economic evaluation of the societal costs of hepatitis B in South Korea. J Gastroenterol Hepatol 2001 16 : 301 308.
13. Leardini G, Salaffi F, Montanelli R, Gerzeli S, Canesi B. A multicenter cost-of-illness study on rheumatoid arthritis in Italy. Clin Exp Rheumatol 2002 20 (4 505 515.
14. Meenan RF, Anderson JJ, Kazis LE et al. Outcome assessment in clinical trials. Evidence for the sensitivity of a health status measure. Arthritis Rheum 1984 27 (12 1344 1352.
15. Stone CE. The lifetime economic costs of rheumatoid arthritis. J Rheumatol 1984 11 (6 819 827.
16. Magnusson S. Treatment of rheumatoid arthritis - does it affect society's cost for the disease?. Br J Rheumatol 1996 35 (8 791 795.
17. Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med 2003 4 : 487 494.
18. Li SC, Ong SC, Lim SG et al. A cost comparison of management of chronic hepatitis B and its associated complications in Hong Kong and Singapore. J Clin Gastroenterol 2004 38 (10 suppl. 3 S136 S143.
19. James L, Fong CW, Foong BH et al. Hepatitis B seroprevalence study 1999. Singapore Med J 2001 42 : 420 424.
20. Merican I, Guan R, Amarapuka D et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000 15 : 1356 1361.
21. Singapore Department of Statistics. Population (Mid-Year Estimates) (available at: http://www.singstat.gov.sg/stats/themes/people/hist/popn.html ; last accessed 3 November 2007).
22. Wai CT, Mak B, Chua W, Lim SG. The majority of hepatitis B carriers are not on regular surveillance in Singapore. Singapore Med J 2004 45 (9 423.
23. Black DAK, Pole JD. Priorities for medical research: indices of burden. Br J Prev Soc Med 1975 29 : 222 227.
24. Rice DP. Cost of illness studies: what is good about them? Inj Prev 2000 6 : 177 179.
25. Ministry of Manpower Statistics. Labour Market Statistics, Ministry of Manpower Statistics, 2003 (available at: http://www.mom.gov.sg/Statistics/ ManpowerResearchNStatistics/LabourMarketStatistics/EarningsandWages-print.htm ; last accessed 29 August 2005).
26. ExpatSingapore. Employing Foreign House Help (available at: http://www.expatsingapore.com/startup/employ.shtml ; last accessed 2 August 2006.
27. Ministry of Health. Government Health Expenditure. Health Facts Singapore. Ministry of Health Singapore, 2005 (available at: http://www.moh.gov.sg/corp/publications/statistics/govthealth.do ; last accessed 29 August, 2005).
28. Kowdley KV. The cost of managing chronic hepatitis B infection: A global perspective. J Clin Gastroenterol 2004 38 : S132 S133.
29. Tan NC, Cheah SL, Teo EK. A qualitative study of health-seeking behaviour of hepatitis B carriers. Singapore Med J 2005 46 (1 6 10.